Isolation of mesenchymal stem-like cells in meningioma specimens

Hyo-Yeol Lim1, Kyung Min Kim, Bo Kyung Kim

  • 1Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Insights

Researchers discovered mesenchymal stem-like cells (MSLCs) in meningioma tumors. These cells, similar to bone marrow mesenchymal stem cells (BM-MSCs), can differentiate and are not tumorigenic, suggesting a role in the meningioma microenvironment.

Area of Science:

  • Neuro-oncology
  • Stem Cell Biology
  • Tumor Microenvironment Research

Background:

  • Mesenchymal stem-like cells (MSLCs) are found in various tissues, including glioma.
  • The presence and characteristics of MSLCs within meningioma tumors remain largely uninvestigated.

Purpose of the Study:

  • To investigate the existence and characteristics of MSLCs in meningioma specimens.
  • To determine if these cells, termed meningioma stroma MSLCs (MS-MSLCs), can be isolated and cultured.
  • To assess the differentiation potential and tumorigenicity of MS-MSLCs.

Main Methods:

  • Meningioma specimens were cultured using established protocols for bone marrow mesenchymal stem cell (BM-MSC) isolation.
  • Isolated cells were analyzed for BM-MSC surface markers via fluorescence-activated cell sorting (FACS).
  • Candidate cells underwent mesenchymal differentiation induction and were tested for tumorigenicity in athymic nude mice. Immunohistochemistry was used to locate MS-MSLCs within tumor sections.

Main Results:

  • Spindle-shaped, adherent cells resembling BM-MSCs were isolated from 2 out of 20 meningioma specimens.
  • FACS analysis confirmed that MS-MSLCs express surface markers similar to BM-MSCs.
  • Isolated MS-MSLCs demonstrated osteogenic, adipogenic, and chondrogenic differentiation capabilities.
  • MS-MSLCs were found to be non-tumorigenic when injected into mice.
  • Immunohistochemistry revealed CD105+ cells in close proximity to endothelial cells and pericytes within meningioma.

Conclusions:

  • This study provides the first evidence for the existence of BM-MSC-like cells within meningioma specimens.
  • These identified MS-MSLCs possess stem cell characteristics, including differentiation potential.
  • MS-MSLCs may represent a cellular component of the meningioma tumor microenvironment.